Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2016

Conditions
Acromegaly
Trial Locations (10)

13005

Hopital De La Conception, Marseille

25030

Hopital jean Minjoz, Besançon

31059

Hopital Larrey, Toulouse

33604

Hopital Haut Leveque, Pessac

38700

Hopital Albert Michallon, La Tronche

42055

Hopital Nord, Saint-Etienne

51092

Hopital Robert Debre, Reims

67098

Hopital De Hautepierre, Strasbourg

69677

Hopital Neuro-Cardiologique, Fédération d'Endocrinologie, Bron

80054

Hoptial Nord, Amiens

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY